PPARG and metabolic syndrome: Consistent with this finding, it was reported that rosiglitazone significantly lowered NEFA and TG levels in Ppargfl/null mice receiving a lipid load, whereas rosiglitazone had no effect on either NEFA or TG levels in the Pparg∆EC/null mice.31 Thus, impaired transendothelial FA transport by loss of PPARγ in capillary ECs modestly affects diet‐induced dyslipidemia.